Clinical Trials Logo
  1. Home
  2. Immunologic Tests
  3. NCT02415842

A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines

Immunologic Tests Clinical Trial

Official title:
An Exploratory, Retrospective Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 HA Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GSK Biologicals' Pandemic Influenza Vaccines

Clinical Trial Summary

The purpose of this exploratory, retrospective laboratory study is to assess the humoral immune response to H1 hemagglutinin stalk domain and other influenza A virus protein epitopes following administration, in adults and children, of GSK Biologicals' adjuvanted and unadjuvanted pandemic influenza vaccines, using archived serum samples from previously completed clinical trials.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02415842
Study type Observational
Source GlaxoSmithKline
Contact
Status Completed
Phase
Start date October 26, 2015
Completion date February 16, 2018
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT00959491 - A Prospective Study of a New Immunological Fecal Occult Blood Test N/A
Completed NCT01098006 - A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays N/A
Completed NCT01099488 - A Study in Healthy Adults Having Received a Single Vaccine Administration to Support the Development of Immunological Assays N/A